SEARCH
Current Location:
>
> This Story

starstarstarstarstar (1)
Log in or Register to rate this News Story
Forward Printable StoryPrint Send us your Comments

Never Miss a Story

Sign up for email alerts

 

More Industry Headlines

With Avicenna, IBM Watson Health interprets radiology images Commercialization preparations are just beginning

Are low dose radiation concerns based on bad science? Loyola research team thinks so Examining the harmful side of dose preoccupation

Toshiba to sell non-imaging health care business in addition to Medical Systems division Stock in the company has hit 35-year low

MR illuminates link between multiple sclerosis, inferior ability to taste MS brain lesions inversely correlate with taste capability: report

Pacemaker and ICD battery life needs to be extended to last 25 years Replacing batteries can lead to life-threatening infections

New telehealth legislation getting support from all angles CONNECT for Health Act gaining bipartisan, industry traction

Calling for a more personalized approach to preventing breast and ovarian cancers Psychological and medical risks need to be considered

Exposing the secrets of voodoo dolls through X-ray Virtual autopsy yields forensic insights in Haitian voodoo crimes

Portable seizure device yields unexpected mood benefits to PTSD patients Reduced sleeplessness, depression and nightmares by 30 percent

MR-compatible cardiac device implants add significant value to patient care A first-of-its-kind study finds value providers may be drawn to

A human embryo that
was fertilized by IVF
(Courtesy of Dr. B. Behr and the
Clinical Embryology Laboratory
at the Stanford IVF Clinic)

A new method predicts the success of in vitro fertilization

by Olga Deshchenko , DOTmed News Reporter
A novel method can help predict with 70 percent accuracy whether a woman undergoing in vitro fertilization (IVF) treatment for the second time will become pregnant, a new study found.

Researchers at the Stanford University School of Medicine identified four factors that determine a woman's chances of getting pregnant from an IVF cycle. Dr. Mylene Yao, an assistant professor of obstetrics and gynecology at the university, led the research.

Story Continues Below Advertisement

CONNECT AS IF LIFE DEPENDS ON IT! Because in many ways it does

And we can help. Conserus™ offers a flexible, vendor-neutral suite of imaging solutions that help orchestrate interoperability between existing systems and among specialists while helping to simplify the transition from volume to value-based care.



"We developed this prediction tool to provide high quality, personalized information that women and their physicians could use to support their decision-making in IVF," Yao wrote in an e-mail to DOTmed News. "This prediction tool also paves the way towards research that will help us better understand mechanisms of infertility."

During an IVF treatment, a woman is given drugs to stimulate ovulation. Her eggs are then removed from the ovaries and combined with sperm in a culture dish. Doctors then use a variety of criteria to determine which embryos produced in the IVF cycle are most likely to result in a live birth. However, the factors doctors take into consideration are not personalized.

According to the Society for Assisted Reproductive Technology, IVF cycles result in pregnancy for women using their own eggs about 18 to 45 percent of the time, depending on age and other variables.

Yao and her team of researchers analyzed clinical data from 665 IVF cycles performed at Stanford in 2005. They examined 30 different variables and looked at the connection of each variable with the IVF outcome. The researchers found that four factors were most important in determining a woman's chance of becoming pregnant through an IVF cycle: total number of embryos, number of eight-cell embryos, percentage of embryos that stopped dividing and would die, and the woman's follicle-stimulating hormone level (a measurement that estimates ovarian function).

Yao said the new method has a lot of implications for women trying to decide to go through a second IVF treatment.

"First, the ability to use information from the first IVF treatment to predict outcomes in subsequent cycles may cause the first IVF treatment to be viewed as a prediction test, in addition to being a treatment," Yao said. "The availability of personalized information may encourage more women to take at least one IVF treatment."

Yao also said patients who may decide to drop out after the first failed treatment can make a more informed decision about continuing with further IVF treatments.

"Results pertaining to the relative influence of each factor with respect to outcome prediction will also form new paradigms for thinking about the causes for IVF, and how to develop treatments that will target specific mechanisms," said Yao.

Yao and her collaborator, Wing Wong, have founded a company together called Univfy Inc. to develop and market the new method, she said.

"We hope to make this technology accessible to patients and physicians nationwide, subject to FDA clearance," Yao said.





Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.
Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2016 DOTmed.com, Inc.
ALL RIGHTS RESERVED